Crossmark Global Holdings’s Zai Lab ZLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,710
Closed -$233K 1393
2021
Q4
$233K Buy
3,710
+1,140
+44% +$96.7K 0.01% 1279
2021
Q3
$271K Sell
2,570
-110
-4% -$15.8K 0.01% 1211
2021
Q2
$474K Buy
2,680
+70
+3% +$11.3K 0.01% 957
2021
Q1
$348K Buy
+2,610
New +$404K 0.01% 1103

Other funds holding ZLAB

Crossmark Global Holdings's ZLAB Position: Q1 2022 in Review

Crossmark Global Holdings sold out of Zai Lab (ZLAB) in Q1 2022, closing a stake of 3,710 shares — an estimated $233K sold.

Crossmark Global Holdings first reported a position in ZLAB in Q1 2021 and held it in 4 quarters. The position peaked at $474K in Q2 2021. 175 funds tracked by Wall St. Rank hold ZLAB as of Q1 2022.

  • Crossmark Global Holdings reported no remaining Zai Lab position as of Q1 2022 after selling out during the quarter.
  • Crossmark Global Holdings sold 3,710 Zai Lab shares in Q1 2022, an estimated $233K.
  • Crossmark Global Holdings first reported a position in Zai Lab in Q1 2021 and held it in 4 quarters.
  • Crossmark Global Holdings's Zai Lab position peaked at $474K in Q2 2021.
  • 175 funds tracked by Wall St. Rank held Zai Lab as of Q1 2022.

Based on Crossmark Global Holdings's 13F filing for Q1 2022, filed 11 May 2022.